Daré Bioscience Inc. (DARE)
NASDAQ: DARE
· Real-Time Price · USD
2.17
0.10 (4.83%)
At close: Aug 15, 2025, 1:19 PM
Daré Bioscience Fail-to-Deliver
Total FTD Shares
338.76K
Above Average
FTD / Avg. Volume
21.93%
High Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Daré Bioscience Inc. has
338,758
shares failed to deliver, representing 21.93%
of the average daily volume of
1,545,040
shares. Over the past year, the monthly average FTD is
15,715
shares, with the current level 2056% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 3.09 | 338.76K | +114345.27% |
| Jun 24, 2025 | 2.67 | 296 | -81.01% |
| May 20, 2025 | 2.89 | 1.56K | +5674.07% |
| Apr 15, 2025 | 2.95 | 27 | -86.01% |
| Mar 13, 2025 | 2.92 | 193 | -99.56% |
| Feb 11, 2025 | 3.14 | 43.45K | +2217.23% |
| Jan 31, 2025 | 3.25 | 1.88K | +544.33% |
| Dec 24, 2024 | 3.2 | 291 | -20.92% |
| Nov 13, 2024 | 3.84 | 368 | +77.78% |
| Oct 31, 2024 | 4.23 | 207 | -2.36% |
| Sep 27, 2024 | 3.27 | 212 | -78.35% |
| Aug 27, 2024 | 3.44 | 979 | +493.33% |
| Jul 30, 2024 | 3.42 | 165 | -99.84% |
| Jun 28, 2024 | 4.03 | 101.63K | +6675.33% |
| May 23, 2024 | 5.46 | 1.5K | -21.30% |
| Apr 15, 2024 | 5.76 | 1.91K | +38.02% |
| Mar 27, 2024 | 6.59 | 1.38K | +423.11% |
| Feb 27, 2024 | 6.01 | 264 | -97.59% |
| Jan 18, 2024 | 3.67 | 10.96K | +475.47% |
| Dec 28, 2023 | 3.91 | 1.9K | -96.65% |
| Nov 29, 2023 | 4.2 | 56.8K | +4045.99% |
| Oct 10, 2023 | 5.56 | 1.37K | -7.81% |
| Sep 28, 2023 | 5.64 | 1.49K | -92.86% |
| Aug 08, 2023 | 8.64 | 20.8K | +2364.45% |
| Jul 21, 2023 | 9.46 | 844 | -96.33% |
| Jun 20, 2023 | 11.58 | 23.03K | +58946.15% |
| May 25, 2023 | 11.8 | 39 | -89.49% |
| Apr 28, 2023 | 12 | 371 | +1136.67% |
| Mar 09, 2023 | 12.48 | 30 | -98.36% |
| Feb 28, 2023 | 12.48 | 1.83K | -79.06% |
| Jan 27, 2023 | 16.26 | 8.73K | n/a |